of the solar system, we talked about this in astronomy and the book, when it was prepared, we were looking for reviewers, and one of the reviewers was the dean of the faculty of geography of moscow state universitye sent him lectures to sergei anatolyevich, asked him make a review, amazingly, but the best reviews, he wrote amazingly that kant could do so deeply. it’s interesting to present geography, a wide variety of geography, physical geography, including issues of astronomy. during the seven years' war in 1758, russian troops entered the capital of prussia and the residents swore allegiance to empress elizabeth petrovna. there is no doubt that kant also swore the oath, but how could it be otherwise? he continued to give lectures on geography in albertina, including for russian students who arrived in kinexberg, because the city was until... 762 part of the russian empire. on july 28, 1794 , immanuel kant was elected a foreign honorary member of the imperial academy of sciences in st. petersburg. the university administration building was built in 1569 in the north-eastern part of the island of kneiphof, right next to the cathedral. it has not survived. the british air force bombing in august

of technological future awaits us and what place will russia take in it? this is a question of science. hello, i’m pavel toropov, associate professor of the faculty of geography of moscow state universitytoday our guest is yulia sukhoroslova, director of development of electronic engineering of the element group of companies. good afternoon. hello, pavel! here is julia, the first question, it seems to me, is urgent, there is a feeling that it is obvious that the demand for microelectronics, for chips will only grow, and there is a feeling that if you look at it with the eye of a geographer, then generally speaking, in connection with geopolitical with all the changes, the market of this industry, well , the geography of this industry is changing rapidly, the market is experiencing fragmentation, this is what awaits us in this regard, very correctly noted, and if historically the industry developed according to the principle. to form vertically integrated players, that is, conventionally, each leading company localized within itself the full cycle of creating a microcircuit from development to its direct production, packaging in a case and for further sale, but now, as the technological

of such phenomena such as allergies? this is a question of science, i am pavel toropov, associate professor of the department of meteorology, climatology, faculty of geography, moscow state universityll, our guest is one of the creators of a promising drug, valery smirnov, head of the research and production complex of the institute of immunology of the federal medical-biological agency of russia. valery, good afternoon. good afternoon, pavel. so, valery, at what stage now? this miracle vaccine is being developed, i’m not afraid of this word. at this stage, we have completely completed preclinical research, that is , animal studies that evaluate the effectiveness and safety of this vaccine, today, together with our strategic industrial partner company, we are finishing the production of a pilot batch according to gnp standards, which will be the result. in order to evaluate the effectiveness of this drug, well, in the future, also continue to evaluate the next dusting season, in order to assess in principle how long the effect of this vaccine can last, of course, well, that’s also a question, maybe a little naive, but can we expect that this will not only be such a counter- counter

of such a phenomenon as allergies? this is a question of science, i’m pavel toropov, associate professor of the department of meteorology, climatology, faculty of geography, moscow state universityll, our guest is one of the creators of a promising drug, valery smirnov, head of the research and production complex of the institute of immunology of the federal medical and biological agency of russia. valery, good afternoon, good afternoon, pavel! so, valery, at what stage is the development of this miracle vaccine now, dare i say it? at this stage, we have completely completed preclinical studies, that is , animal studies that evaluate the effectiveness and safety of this vaccine, at the moment, together with our strategic industrial partner generium, we we are finishing production of a pilot one. against which it will be possible to make a similar vaccine, most likely it will also be a vaccine against pollen, but other plants, for example, if we take the southern regions, allergies to ragweed pollen are more typical there than to birch pollen, at least there are also birch pollen, therefore this can be called a whole platform for creating this kind of vaccine, the principle will

of such a phenomenon as allergies? this is a question of science, i'm pavel. toropov, associate professor, department of meteorology climatology, faculty of geography, moscow state universityour guest is one of the creators of a promising drug, valery smirnov, head of the research and production complex of the institute of immunology of the federal medical-biological agency of russia. valery, good afternoon. good afternoon, pavel. so, valery, at what stage is the development of this miracle vaccine now? i'm not afraid of this word. at this stage, we have completely completed preclinical studies, that is, they have been studied. it will go on sale there in a couple of years, or after all, a couple or three years is a good period, so to speak , because due to the fact that. that birch pollen, thank god, produces dust once a year, we must at least wait for one dusting season in order to evaluate the effectiveness of this drug, and then continue to evaluate the next dusting season in order to assess in principle how long the effect can last from this vaccine, of course, well, that’s also a question, maybe a little naive. is it possible to count that this will not only be such